Phase II Study of MP-424 in Patients With (Genotype 1b) Hepatitis C
Phase II Study of MP-424 in Patients With (Genotype 1b) Hepatitis C
The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.
Inclusion Criteria:
Exclusion Criteria: